Search results for II

Anti-Sahara scorpion AaH II/Neurotoxin II Nanobody (SAA2040), AntibodySystem, RWN10303

Anti-Sahara scorpion AaH II/Neurotoxin II Nanobody (SAA2041), AntibodySystem, RWN10304

Anti-Sahara scorpion AaH II/Neurotoxin II Nanobody (SAA2042), AntibodySystem, RWN10305

Major Histocompatibility Complex Class II (MHC Class II) Antibody, Abbexa, abx137082

Major Histocompatibility Complex Class II (MHC Class II) Antibody is a Mouse Monoclonal antibody against Major Histocompatibility Complex Class II (MHC Class II).

Major Histocompatibility Complex Class II (MHC Class II) Antibody, Abbexa, abx137083

Major Histocompatibility Complex Class II (MHC Class II) Antibody is a Mouse Monoclonal antibody against Major Histocompatibility Complex Class II (MHC Class II).

Anti-RbcL II | Rubisco large subunit, form II antibodies, Agrisera, AS15 2955

The antibody does not detect Form I RbcL/cbbL

Human C-telopeptide of type II collagen (CTX-II) ELISA Kit, Abbkine, KTE62194

• Do not mix components from different kit lots or use reagents beyond the kit expiration date.• Allow all reagents to warm to room temperature for at least 30 minutes before opening.• Pre-rinse the pipet tip with reagent, use fresh pipet tips for each sample, standard and reagent to avoid contamination. • Unused wells must be kept desiccated at 4 °C in the sealed bag provided.• Mix Thoroughly is very important for the result. It is recommended using low frequency oscillator or slight hand shaking every 10 minutes.• It is recommended that all samples and standards be assayed in duplicate or triplicate.

Major Histocompatibility Complex Class II (MHC Class II) Antibody (Biotin), Abbexa, abx347127

Major Histocompatibility Complex Class II (MHC Class II) Antibody is a Rat Monoclonal against Major Histocompatibility Complex Class II (MHC Class II).

PE Anti-Topoisomerase II alpha + Topoisomerase II beta antibody [EPR5377], Abcam, AB306108

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

APC Anti-Topoisomerase II alpha + Topoisomerase II beta antibody [EPR5377], Abcam, AB306109

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .